FDA’s final CMC guidance sets expectations for manufacturing and quality for human gene therapy INDs. This article reviews existing analytical applications, focusing on viral vector characterization of impurities.
Stephen Gacheru
Advertisement
Articles by Stephen Gacheru
Advertisement
Latest Updated Articles
Viral Vector API Characterization of Product-Related ImpuritiesPublished: October 16th 2020 | Updated:
Advertisement
Advertisement
